Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity?: Evidence from animal studies

 Abstract

There is substantial evidence for broad cross-reactive immunity and heterotypic protection among human rotavirus strains in children with natural infection or with monovalent Rotarix vaccination. In this commentary, we addressed this same topic by testing sera of guinea pigs and gnotobiotic piglets that were intramuscularly immunized with an inactivated human rotavirus vaccine and also demonstrated a broad cross-protective immunity among human rotavirus strains. Our findings from a single human strain in animal studies bode well for a low cost and efficacious inactivated vaccine to protect children against rotavirus disease throughout the world.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1634 - 1637
doi
10.4161/hv.24958
Type
Commentary
Group
Rotavirus
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity?: Evidence from animal studies